Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Depreciation & Amortization (CF) (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Depreciation & Amortization (CF) readings, the most recent being $257000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 13.22% to $257000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $951000.0, a 15.62% decrease, with the full-year FY2025 number at $930000.0, down 9.44% from a year prior.
  • Depreciation & Amortization (CF) hit $257000.0 in Q4 2025 for Aligos Therapeutics, up from $200000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $800000.0 in Q2 2021 to a low of $194000.0 in Q1 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $417500.0 (2023), compared with a mean of $453950.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 47.82% in 2024 and later increased 13.22% in 2025.
  • Aligos Therapeutics' Depreciation & Amortization (CF) stood at $709000.0 in 2021, then fell by 27.22% to $516000.0 in 2022, then dropped by 15.7% to $435000.0 in 2023, then plummeted by 47.82% to $227000.0 in 2024, then grew by 13.22% to $257000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $257000.0 (Q4 2025), $200000.0 (Q3 2025), and $300000.0 (Q2 2025) per Business Quant data.